Rana, S.; Mallareddy, J.R.; Singh, S.; Boghean, L.; Natarajan, A.
Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase. Cancers 2021, 13, 5506.
https://doi.org/10.3390/cancers13215506
AMA Style
Rana S, Mallareddy JR, Singh S, Boghean L, Natarajan A.
Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase. Cancers. 2021; 13(21):5506.
https://doi.org/10.3390/cancers13215506
Chicago/Turabian Style
Rana, Sandeep, Jayapal Reddy Mallareddy, Sarbjit Singh, Lidia Boghean, and Amarnath Natarajan.
2021. "Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase" Cancers 13, no. 21: 5506.
https://doi.org/10.3390/cancers13215506
APA Style
Rana, S., Mallareddy, J. R., Singh, S., Boghean, L., & Natarajan, A.
(2021). Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase. Cancers, 13(21), 5506.
https://doi.org/10.3390/cancers13215506